From professional translators, enterprises, web pages and freely available translation repositories.
pegaptanib
pegaptanib
Last Update: 2014-11-25
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pegaptanib-natrium.
- the active substance is pegaptanib sodium.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
0,3 mg pegaptanib-natrium.
0.3 mg pegaptanib sodium.
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
macugen 0,3 mg injektion pegaptanib
macugen 0.3mg injection pegaptanib
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
macugen 0,3 mg injektionslösung pegaptanib-natrium
macugen 0.3 mg solution for injection pegaptanib sodium
Last Update: 2012-04-10
Usage Frequency: 6
Quality:
pegaptanib wird mittels endo- und exonukleasen metabolisiert.
pegaptanib is metabolised by endo- and exonucleases.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
es gibt keine studien von pegaptanib mit schwangeren frauen.
pegaptanib has not been studied in pregnant women.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
macugen enthält den arzneilich wirksamen bestandteil pegaptanib-natrium.
macugen contains the active ingredient pegaptanib sodium.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
pegaptanib 0,3 mg 67% versus scheininjektionen 52%, p = 0,0031.
6 at one year, pegaptanib 0.3 mg exhibited a statistically significant treatment benefit for the primary efficacy endpoint; proportion of patients losing less than 15 letters of visual acuity (prespecified pooled analysis, pegaptanib 0.3 mg 70% versus sham 55%, p = 0.0001; eop 1003 pegaptanib 0.3 mg 73% versus sham 59%, p = 0.0105; eop1004 pegaptanib 0.3 mg 67% versus sham 52%, p = .0031).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3 mg pegaptanib mittels intravitrealer injektion über einen zeitraum von 48 wochen.
patients were randomised to receive sham or 0.3 mg, 1 mg or 3 mg pegaptanib administered as intravitreal injections every 6 weeks for 48 weeks.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
nach okulärer verabreichung ist die systemische pegaptanib-exposition vermutlich sehr gering.
the systemic exposure to pegaptanib is expected to be very low after ocular administration.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
bei tieren unterliegt pegaptanib nach intravitrealer verabreichung einer langsamen systemischen resorption aus dem auge.
in animals, pegaptanib is slowly absorbed into the systemic circulation from the eye after intravitreal administration.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
bei kaninchen wird pegaptanib als unveränderte substanz und in form von metaboliten hauptsächlich mit dem harn ausgeschieden.
in rabbits, pegaptanib is eliminated as parent drug and metabolites primarily in the urine.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
die resorptionsrate aus dem auge ist beim tier und vermutlich auch beim menschen der limitierende faktor für die verfügbarkeit von pegaptanib.
the rate of absorption from the eye is the rate-limiting step in the disposition of pegaptanib in animals and is likely to be in humans.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
== dosierung ==pegaptanib wird in dosen à 0,3 mg einmal in sechs wochen intravitreal injiziert.
==means of administration==pegaptanib is administered in a 0.3 mg dose once every six weeks by intravitreal injection.
Last Update: 2016-03-03
Usage Frequency: 2
Quality:
akute (am tag der injektion) und spätere intravitreale blutungen können nach injektionen von pegaptanib auftreten.
immediate (on the day of injection) and delayed intravitreous haemorrhages may occur following pegaptanib injections.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
bei dosierungen unter 0,5 mg / auge sind die plasmakonzentrationen von pegaptanib wahrscheinlich nicht höher als 10 nanogramm / ml.
at doses below 0.5 mg/ eye, pegaptanib plasma concentrations do not likely exceed 10 ng/ ml.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
pegaptanib-natrium wurde bei patienten mit einer kreatinin-clearance unter 20 ml / min nicht ausreichend untersucht.
pegaptanib sodium has not been adequately studied in patients with creatinine clearance below 20 ml/ min.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
nach markteinführung wurden fälle von anaphylaktischem schock / anaphylaktoiden reaktionen einschließlich quincke-Ödemen nach der intravitrealen anwendung von pegaptanib berichtet.
cases of anaphylaxis/ anaphylactoid reactions, including angioedema, have been observed within several hours after the pegaptanib intravitreal administration procedure in the post-marketing experience.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
1 fertigspritze zur einmalgabe mit einem nominalvolumen von 90 mikrolitern enthält 1,65 mg pegaptanib-natrium, entsprechend 0,3 mg der freien säure des oligonukleotids.
a single dose pre-filled syringe delivers 1.65 mg pegaptanib sodium, corresponding to 0.3 mg of the free acid form of the oligonucleotide, in a nominal volume of 90 microlitres.
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.